17P-Estradiol (0.44 to 4.4 &kg) was intramuscularly administered to pregnant rabbits on day 25 or 26 of gestation, and the fetuses were delivered by cesarean section 24 hr later. On light microscopy, the lungs from the treated group had larger alveoli and thinner interalveolar septa than did those from the controls at the same gestational age. The 1umen:septa ratio was 0.62 + 0.06 in the control group and 0.88 + 0.05 in the treated group ( P < 0.01). Blood vessels in the lungs of the treated group were also more mature than were those in the control group. Alveolar epithelial cells consisted of 52% undifferentiated, 21% type 11, and 27% type I cells in the control group. In the estrogen-treated group, the corresponding distribution was 25, 29, and 45%. There were 0.82 -+ 0.16 lamellar bodies per alveolar cell in the treated group compared to 0.38 k 0.06 in the controls (P < 0.05). Estrogen decreased fetal lung glycogen content from 247 + 15 pg/mg protein to 70 9 on day 26 and from 103 -+ 13 to 13 + 2 on day 27 ( P < 0.001). Estrogen administration increased the rate of incdrporation of choliie into phosphatidylcholine in fetal lung slices. decreased the rate of thymidine incorporation into DNA, but had no effect on the rates bf incorporatibn of ethanolamine into phosphatidylethanolamine or of leucine into protein. These data indicate that estrogen accelerates the rate of fetal lung maturation. It appears to stimulate lung differentiation at the expense of lung growth.
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Speculation
Estrogen may be involved in the physiologic control of fetal lung maturation and pulmonary surfactant production.
We have previously shown that administration of 17/3-estradiol to pregnant rabbits at 25 to 26 days gestation (term is 31 days) accelerates fetal lung maturation and stimulates production of pulmonary surfactant (16, 17) . Thus, maternal estrogen administration has the following effects on the fetal lung: it increases the amount of total phospholipid and phosphatidylcholine as well as the phosphatidylcholine:sphingomyelin ratio in lung lavage (17) , it increases the rate of choline incorporation into phosphatidylcholine in lung slices (16) , and it increases the activities of pulmonary cholinephosphate cytidylyltransferase and lysolecithin acyltransferase (16) , enzymes involved in the synthesis of total and disaturated phosphatidylcholine, respectively (33) . Gross et al. (12) reported that estrogen accelerates maturation of fetal rat lung in organ culture. This fmding suggests that estrogen has a direct effect on the fetal lung.
The purpose of the present study was to further characterize the effects of estrogen on fetal lung maturation. Inasmuch as there are distinct morphological changes during maturation of the fetal lung (2), we examined the effects of estrogen on these parameters of lung maturation. In addition, we determined the effect of estrogen on lung glycogen content because this decreases toward the end of gestation in a number of species (4, 23, 36) , and it has been postulated that glycogen may provide substrate or energy for surfactant phospholipid synthesis in fetal lung (18, 23) . Finally, we examined the effect of estrogen on the rate of synthesis of a nonsurfactant lung phospholipid, phosphatidylethanolamine, as well as on that of lung protein and DNA.
MATERIALS AND METHODS

ANIMALS
Pregnant rabbits (New England White) whose time of breeding was known to within 2 hr were obtained from Plummer Rabbitry, Grafton, VT. The day of mating was considered day 0. 17,BEstradiol in propylene glycol was administered to the doe intramuscularly on days 25 or 26 of gestation. Control animals were similarly administered vehicle alone. Twenty-four hr later, the does were killed with intravenous sodium pentobarbital (80 mg/ kg), and the fetuses were delivered by cesarean section. The newborns were killed by decapitation.
CHEMICALS
Radioisotopes were obtained from New England Nuclear Corp., Boston, MA; mithramycin (Mithracin) was obtained from Pfizer Laboratories, New York, NY, and other biochemicals were obtained from Sigma Chemical Co., St. Louis, MO. Other chemicals were reagent grade or better.
MORPHOLOGY
Lungs were immediately excised and fixed in 10% formalin for light microscopy or in 3% glutaraldehyde and processed as described previously (10) for electron microscopy. The lungs were inflated to intrathoracic volume with the fixative. Only the right apex was used for the morphologic studies. Morphologic changes in both light and electron microscopic preparations were quantitated. Changes in air spaces were quantitated by the point counting technique described by Weibel (37) . Light microscopic slides (1 to 2 per fetus) were prepared from 2 to 3 fetuses from each of 12 control and 20 estrogen-treated litters. Each slide was projected onto a screen onto which was also projected a grid with 100 equidistant points. The ratio of the number of points falling on air spaces to those falling on the epithelium or interstitium was measured. Each slide was projected twice.
One or two blood vessels of 50 to 100 pm diameter with an identifiable muscular media near a cartilaginous bronchus were examined from 1 to 2 fetuses from eight control and eight estrogen-treated litters. The ratio of the lumen diameter to the thickness of the blood vessel wall was measured on photomicrographs.
Electron micrographs of 50 to 150 epithelial cells per litter from five control and six estrogen-treated litters were examined. Only cells with a completely identifiable outline and nucleus were included. The epithelial cells were categorized into three groups: undifferentiated, type 11, and type I cells. Tall columnar cells with elongated basal nuclei containing large amounts of glycogen and with relatively few microvilli on the apical surface were identified as undifferentiated cells. Cuboidal cells with large numbers of microvilli on the luminal surface containing lamellar bodies and appreciable amounts of glycogen were classified as type I1 cells. Cuboidal or flat cells with cytoplasmic extensions devoid of glycogen were classified as type I cells. Lamellar bodies in type I1 cells were counted. Lamellar bodies in the lumen were also noted. In two-dimensional photographs, the apparent increase in lamellar bodies could be due to increased size or increased numbers.
Morphometric data from each litter were pooled for statistical analysis.
GLYCOGEN ANALYSIS
Lungs and livers were rapidly excised, immediately frozen in acetone-solid COz, and stored at -70°C until analyzed. Glycogen was measured fluorometrically as described previously (23) . Under these conditions, the rates of choline and ethanolamine incorporation into phosphatidylcholine and phosphatidylethanolamine, respectively, were linear for at least 3 hr, whereas those of leucine and thymidine into protein and DNA, respectively, were linear for at least 1.5 hr. The reactions were stopped in ice-water, and the slices were thoroughly washed with ice-cold 0.9% NaCl solution. The tissue was homogenized, and aliquots were removed for protein assay and for product measurement. Lipids were extracted, and radioactive phosphatidylcholine and phosphatidylethanolamine were measured as described previously (34) . Aliquots for measurement of radiolabeled protein and DNA were applied to 2.3 cm disks of Whatman 3 MM filter paper which were immediately plunged into ice-cold 10% trichloroacetic acid containing 0.2 mM leucine or thymidine, respectively (24) . After 1 hr, the 10% trichloroacetic acid was decanted, and the disks were resuspended in ice-cold 5% trichloroacetic acid twice for 15 min each and in ethanokdiethyl ether (50:50 v/v) for 45 min. The disks were finally rinsed with diethyl ether and air dried, and the radioactivity content was measured in Econofluor (New England Nuclear Corp.).
Variations in slice thickness as well as in uptake of the radiolabeled precursor into the slice could influence the apparent rate of incorporation of precursor into product. In measuring the rate of incorporation of choline into phosphatidylcholine in fetal lung slices, Epstein and Farrell (7) corrected for this by measuring the precursor radioactivity in the upper (aqueous) phase of the chloroform:methanol:water extraction mixture. We have similarly corrected the rates of incorporation of choline and ethanolamine into phosphatidylcholine and phosphatidylethanolamine, respectively. We have made a similar adjustment in the case of protein and DNA synthesis. Aliquots of the homogenized slices were applied to filter paper disks and dried, and the radioactivity content was measured. The difference between the total radioactivity on the disk and the radioactivity after the washing procedure (macromolecular radioactivity) was taken as precursor radioactivity. 
RESULTS
On light microscopy, the lungs of the estrogen-treated animals at 26 days gestation appeared more mature than did those of the controls. Figure I shows that the air spaces were larger in the treated group than in the controls. The interstitial tissue in the treated group was generally 1 to 3 cells thick compared to 3 to 5 cells thick in the control group. Point-counting morphometric analysis showed that the ratio of alveolar space to interstitium increased bv 42% from 0.62 -t 0.06 (S.E.1 in the control From to , , " 1 0.88 + 0.05 in the estrogen-treated group (P < 0.01).
The effect of estrogen on fetal lung blood vessels at 26 days gestation is shown in Figure 2 and Table 1 . Blood vessels from the estrogen-treated group appeared more mature than did those in the control group. The lumen appeared larger and the wall thinner. These changes were quantitated by morophometric analysis (Table 1 ). Blood vessels of approximately the same size were examined in both groups. The lumen diameter was 62% greater in the estrogen-treated group than in the controls. There was a tendency towards thinner walls in the estrogen-treated group, but this change was not statistically significant. However, the lumen diameter-to-wall thickness ratio was twice as great in the treated group as in the controls.
The effects of estrogen on fetal rabbit lung at 27 days gestation at the electron microscopic level are summarized in Table 2 . There were 67% more type I epithelial cells and 52% fewer undifferentiated epithelial cells in the estrogen-treated group than in the control group. These changes were statistically significant. There were also 38% more type I1 cells in the treated group, but this change was not statistically significant. On the other hand, lamellar bodies appeared twice as frequently in alveolar lining cells in the treated group than the control group. Representative electron micrographs are shown in Figure 3 . Loss of glycogen in the estrogen-treated group was one of the most striking observations. Another feature of the treated group was that most of the type I cells had very long, thin cytoplasmic extensions so that often the alveolar capillary barrier was reduced to a thin septa1 structure reminiscent of adult lung. Many of the alveoli were lined with only one or two such cells. This feature was almost entirely absent in the control group. Lamellar bodies were frequently seen in the alveolar lumen of the treated group (Fig. 3C) but very rarely in that of the control group.
The effect of estrogen on fetal lung glycogen content is shown in Table 3 . The amount of glycogen in the lungs of control animals decreased significantly between 26 and 27 days gestation. There was only 42% as much glycogen at 27 days as at 26 days (P < 0.001). Estrogen administration reduced the amount of lung glycogen by 72% at 26 days and by 87% at 27 days. The effect of estrogen on l~n g glycogen was dose dependent (Fig. 4) . There was only a 34% decrease at 0.44 pg/kg but the maximum decrease was obtained at 1.1, 2.2 and 4.4 &kg.
In contrast to the lung, estrogen had no effect on fetal liver glycogen content (Table 3) . It is of interest that at the stage of gestation examined the glycogen content in the lung was consid- erably greater than that in the liver. In contrast to the lung, liver also stimulated, we examined the effect of estrogen on the rate of glycogen increases towards the end of gestation (36) .
incorporation of ethanolamine into phosphatidylethanolamine in We have previously shown that estrogen stimulates the rate of fetal lung slices. To determine if estrogen has a general effect on synthesis of phosphatidylcholine in fetal rabbit lung (16) . To lung growth, we also measured its effect on the rates of incorpodetermine if this is a specific effect on phosphatidylcholine syn-ration of leucine into protein and of thymidine into DNA. In thesis or if the rates of synthesis of other lung phospholipids are these experiments, to ensure that the stirnulatory effect of estrogen on phosphatidylcholine synthesis occurred, we also measured the rate of choline incorporation into phosphatidylcholine. The data are shown in Table 4 . Estrogen stimulated the rate of choline incorporation into phosphatidylcholine by 44% but had no effect on the rate of incorporation of ethanolamine into phosphatidylethanolamine or of leucine into protein. On the other hand, it decreased the rate of thymidine incorporation into DNA by 44%. In the slice studies, pool sizes of the various precursors and intermediates are unknown. Thus, a change in pool size could alter the rate of radioisotope incorporation. Nevertheless, changes in the rate of choline incorporation into phosphatidylcholine have been correlated with changes in enzyme activities in previous studies on the effects of hormones on fetal lung maturation (5, 16, 34) . Thus, rates of incorporation may approximate rates of synthesis.
To determine if the decrease in the rate of incorporation of Fig. 2 . Pulmonary arteries from lungs described in Figure I . A , control; B, estrogen-treated; PA, pulmonary artery; BR, bronchus (hernatoxylin and eosin; original magnification, x 250). ' 17p-Estradiol (4.4 pg/kg) or vehicle was administered to the doe on day 25 of gestation, and the animals were killed on day 26. One or two blood vessels, 50 to 100 pm in diameter, from one to two fetuses in each of eight control and eight estrogen-treated litters were examined. Mean values from each litter were analyzed statistically. M e a n -I S.E.
'' N.S., not significant ( P > 0.05). thymidine into DNA was reflected in decreased end product, we However, these changes were not statistically significant. It is measured the effect of estrogen on lung DNA content. We also possible that if a higher dose of estrogen were used or if the measured lung protein content, lung weight, and total body weight. animals were killed more than 24 hr after hormone administration, The results are shown in Table 5 . Estrogen had no effect on fetal the tendency towards smaller lungs with decreased DNA content weight. However, lung wet and dry weight, protein and DNA would become more apparent. content as well as lung weight as a fraction of fetal weight were all 8 to 15% less in the estrogen-treated group than in the controls. The protein:DNA ratio was 24% greater in the treated group. Lung development in late gestation is characterized by morphologic and biochemical changes that prepare the organ for adequate postnatal gas exchange. We have previously shown that estrogen stimulates surfactant production by the fetal rabbit lung (16, 17) . We have now extended these studies and demonstrated that estrogen accelerates morphologic maturation of the fetal lung.
Morphologic maturation of the fetal lung has been extensively reviewed by others (2) . Inasmuch as maturation proceeds from apex to base, we consistently examined the right upper lobe to avoid variation in lobar development. The data show that maternal estrogen administration accelerates morphologic maturation of fetal lung as shown by the following evidence: (1) increased alveolarization; (2) increased number of alveolar epithelial type I1 and type I cells and decreased numbers of undifferentiated epithelial cells; (3) increased appearance of lamellar bodies in type I1 cells and in the alveolar lumen; and (4) decreased lung glycogen content.
Estrogen administration also resulted in maturation of the fetal lung vasculature. A similar observation was previously made by Abdul-Karim and Prior (1) who reported that administration of the anti-estrogen ethamoxytriphetol (MER-25) to pregnant rabbits resulted in the fetal lung blood vessels having thicker walls, narrower lumens, and a decreased lumen-to-wall ratio than the controls. These changes were not seen when 17P-estradiol was administered together with ethamoxytriphetol. The effect of estrogen alone, however, was not examined in that study.
When we examined the data in this study, the depletion of fetal lung glycogen after estrogen administration was striking. It has been reported elsewhere (12) that in fetal rat lung explants 17P-estradiol decreased lung glycogen although the effect was much less marked than in the present study. Glucocorticoids also decrease lung glycogen both in fetal rabbits in vivo (8, 34) and in Table 3 .
Effect of I7P-Estradiol on fetal rabbit lung and liver glycogen content1
Glycogen content (,ug/mg protein) Gestational age (days) Tissue Control Estrogen-treated P Lung Lung Liver 17P-Estradiol (1.1 to 4.4 &kg) or vehicle was administered to the doe 24 hr before sacrifice. The 26-day lung data are from 19 control and nine treated litters, the 27 day data are from three control and three treated litters, and the liver data are from five control and seven treated litters.
Numbers in parentheses, numbers of fetuses. N.S., not statistically significant ( P > 0.05). data are from five control and seven estrogen-treated litters. All other data between the two groups were not statistically significant (P > 0.05).
' Mean + S.E.
Numbers in parentheses, number of fetuses.
fetal rat lung explants (13) . Thyroxine (13), as well as aminophylline, and cyclic adenosine 3':5' monophosphate (22) , other agents which accelerate fetal lung maturation (33) , also decreases fetal lung glycogen. On the other hand, insulin, which appears to delay fetal lung maturation, increases the glycogen content of fetal rat lung explants (1 1). Thus, agents which stimulate fetal lung maturation and surfactant production decrease fetal lung glycogen whereas an agent which may delay fetal lung maturation has the opposite effect. During normal development, there is a decrease in fetal lung glycogen towards the end of gestation (4, 23, 36) . In the rabbit, this occurs about the time lamellar inclusions in type I1 cells appear (18) . In the rat, it coincides with the increase in the rate of holine incorporation into phosphatidylcholine (23) . The temporal relationship between glycogen depletion and events associated with increased surfactant production has led to speculation that glycogen may provide substrate or energy for surfactant production (1 8, 23) . A direct precursor-product relationship, however, has not been demonstrated. In comparing results from investigations conducted by this laboratory and others on lung maturation, a number of noteworthy similarities were found between the effects of estrogen and glucocorticoids. Both accelerate morphologic maturation of the fetal lung (18) and deplete its glycogen content (8, 34) . Both increase the amount of phosphatidylcholine as well as the phosphatidylcho1ine:sphingomyelin ratio in lung lavage and increase the rate of choline incorporation into phosphatidylcholine in lung slices (33) . Both hormones stimulate fetal lung cholinephosphate cytidylyltransferase and lysolecithin acyltransferase activities (33) . In contrast, glucocorticoids stimulate fetal lung phosphatidate phosphatase (5, 30, 34) , whereas estrogen does not (16) . Estrogen increases the amount of total phospholipid and phosphatidycholine in lavaged lung tissue (17) whereas glucocorticoids do not (34) .
Fetal body weights have been reported to be both unaffected (6) and decreased (27, 30) by glucocorticoids. Fetal lung weights and lung weight:body weight ratios were decreased by glucocorticoids (6, 30) as were fetal lung protein and DNA contents (6) . The rates of incorporation of methionine into protein (30) and of thymidine into DNA (35) were also decreased by glucocorticoids. Except for the incorporation of thymidine into DNA, this study demonstrates that the effects of estrogen on these parameters were not statistically significant but tended to produce the same results as did the effects of glucocorticoids. These findings imply that both estrogen and glucocorticoids stimulate lung differentiation at the expense of lung growth.
It is now generally accepted that the effects of glucocorticoids on fetal lung are mediated via glucocorticoid receptors (3). Estrogens do not bind to the glucocorticoid receptor in the fetal lung (3). Thus, estrogens must act via another mechanism. Inasmuch as estrogen accelerates the maturation of fetal rat lung explants in vitro (12) , it is likely that it acts directly on the lung rather than y 25 of gestation, and the fetuses were delivered on day 26. The fetal weight are from three control and three estrogen-treated litters. The differences indirectly via other organs. Estrogen receptors have been reported in adult rat lung (26) and fetal guinea pig lung (29) . Recent studies by Mendelson et al. (25) on the human fetus and by Khosla et al. (unpublished observations) on the fetal rabbit in this laboratory have shown that the estrogen binder in fetal lung is not the classical estrogen receptor. The role, if any, of the estrogen binder in mediating the effects of estrogen on fetal lung maturation is not clear.
A role for sex hormones in the regulation of fetal lung maturation is suggested by recent reports. Both in humans (28) and rabbits (19) , female fetal lungs are more mature than those of males at the same gestational age. Umbilical artery 17P-estradiol levels were significantly higher in female fetal rhesus monkeys than in males after 150 days gestation (31) . There was little difference between the sexes before 150 days. In midgestation human pregnancies, amniotic fluid 17P-estradiol levels were also higher in female fetuses than in males (32) . However, androgen levels were higher in male fetuses (32) .
In summary, the data in this paper together with previous data from this laboratory (12, 16, 17) show that estrogen can accelerate fetal lung maturation and stimulate pulmonary surfactant production. Estrogen levels are known to increase towards the end of gestation in many species. In the human, the increase in plasma estrogens during pregnancy (20) appears to precede the surge in surfactant production by the fetus as determined by an increase in the amniotic fluid 1ecithin:sphingomyelin ratio (14) . Low fetal estrogen levels have been reported to be associated with the respiratory distress syndrome (9) . It is possible that estrogens play a role in the physiologic regulation of fetal lung maturation. However, there is as yet no direct evidence in support of this.
